Ciprofloxacin-Induced Acute Generalized Exanthematous Pustulosis Mimicking Bullous Drug Eruption Confirmed by a Positive Patch Test

Dermatology ◽  
2005 ◽  
Vol 211 (3) ◽  
pp. 277-280 ◽  
Author(s):  
P. Häusermann ◽  
K. Scherer ◽  
M. Weber ◽  
A.J. Bircher
Keyword(s):  
Patch Test ◽  
Drug Eruption ◽  
Positive Patch Test ◽  
Acute Generalized Exanthematous Pustulosis ◽  
Exanthematous Pustulosis

Terbinafine-induced acute generalized exanthematous pustulosis confirmed by a positive patch-test result

1997 ◽  
Vol 37 (4) ◽  
pp. 653-655 ◽  
Author(s):  
Anne Kempinaire ◽  
Linda De Raevea ◽  
Myriam Merckx ◽  
Arlette De Coninck ◽  
Martine Bauwens ◽  
...  
Keyword(s):  
Patch Test ◽  
Positive Patch Test ◽  
Acute Generalized Exanthematous Pustulosis ◽  
Exanthematous Pustulosis ◽  
Test Result

scholarly journals Acute Generalized Exanthematous Pustulosis due to Pseudoephedrine with Positive Patch Test

2006 ◽  
Vol 86 (6) ◽  
pp. 542-543 ◽  
Author(s):  
E Mayo-Pampín ◽  
? Flórez ◽  
C Feal ◽  
A Conde ◽  
MT Abalde ◽  
...  
Keyword(s):  
Patch Test ◽  
Positive Patch Test ◽  
Acute Generalized Exanthematous Pustulosis ◽  
Exanthematous Pustulosis

Celecoxib-induced erythema multiforme-type drug eruption with a positive patch test

2011 ◽  
Vol 38 (12) ◽  
pp. 1185-1188 ◽  
Author(s):  
Yukiyasu ARAKAWA ◽  
Noriaki NAKAI ◽  
Norito KATOH
Keyword(s):  
Patch Test ◽  
Erythema Multiforme ◽  
Drug Eruption ◽  
Positive Patch Test

scholarly journals Mucosal Fixed Drug Eruption to Levetiracetam with Early Positive Patch Test on Non-Lesional Skin

2021 ◽  
Author(s):  
Nazli Ercan
Keyword(s):  
Patch Test ◽  
Broad Spectrum ◽  
Drug Eruption ◽  
Hepatic Metabolism ◽  
Fixed Drug Eruption ◽  
Pediatric Case ◽  
Lesional Skin ◽  
Positive Patch Test ◽  
Low Protein ◽  
Fixed Drug

Levetiracetam (LEV) is a second-generation antiepileptic drug (AED) that is well tolerated, has a broad spectrum of action, low protein binding, and minimal hepatic metabolism. The incidence of hypersensitivity to LEV in children and adults is 0.6%. This is the first reported fixed drug eruption (FDE) identified using a patch test in a pediatric case associated with LEV

Sign in / Sign up

Export Citation Format

Share Document